Andere talen Innoveren Scientific Inc.

Aandelen

IVRN

US4041243076

Vertraagde tijd OTC Markets Andere beurzen 17:46:52 17-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,02 ^USD	-33,33%		0,00%	-82,76%

06/03	Innoveren Scientific kondigt 510(K) indiening aan bij de U.S. Federal Food and Drug Administration voor Skindisc(Tm) Lite	CI
2023	Innoveren Scientific Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	06/03
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/11
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	10-07-23
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	10-07-23
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22-05-23
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	10-05-23
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	10-05-23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	18-04-23
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	12-04-23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02-03-23
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	24-02-23
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC	29-12-22
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	29-12-22
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	28-12-22
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14-11-22
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	07-10-22
H-CYTE, Inc. announced that it has received $0.225 million in funding	29-09-22
H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days	19-09-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Innoveren Scientific Inc.

Aandelen

IVRN

US4041243076

Andere talen

Filters